Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (241)	12/20/1999 10:51:00 PM
From: Larry Liebman	Read Replies (2) \| Respond to of 359

Pretty remarkable when you consider the tenor of the biotech boards just this Spring. I recall that prescient call by a biotech analyst that mini-caps were doomed to extinction. Looking at GENE, HYSQ, MEDX, CBST, etc., et al, I'm pleased to have played the contrarian. Now if ARIA would continue its mini-move........

To: scaram(o)uche who wrote (241)	12/21/1999 2:42:00 AM
From: GeoDude	Read Replies (1) \| Respond to of 359

Of course if one had been wise enough to buy in June (like it appears you did) during that short period where it was at $5 it is a triple. But on average the price for the year is $8 or $9. My average cost is $10.25. Started buying in January of 1999. The stock was 11 a few days ago (where I bought more) for a less than 10% return in 11 months. So for me (who obviously does not have your great timing) it has been a long time coming. Especially if I compare with my CELG (in at 18), NBIX (in at 5.90), MLNM (in at 26) and a few others which do not have .com in their name. I understand what you are saying but there is always two sides (or more) to a story. Now, do you know why ABSC shot up yesterday?